Phase 4 Lupus Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 18 and 80 years old
- You have been diagnosed with systemic lupus erythematosus (lupus/SLE) based on recognised medical guidelines
- You have been diagnosed with a specific type of kidney inflammation caused by lupus (called proliferative lupus nephritis, class III, IV, or V), confirmed by a kidney biopsy
- Your kidneys are working at a reasonable level, as measured by a specific kidney function test (confirm with trial site for exact values)
- You are able to take certain medications used in this trial, including Methylprednisolone, Mycophenolate mofetil, steroids, or Rituximab, without medical contraindications
- You are able to understand and sign a consent form agreeing to take part
Who may not be able to join:
- You are under 18 years old
- You have life-threatening complications from your lupus, such as brain inflammation
- Your kidney function is too low, as measured by a specific kidney function test (confirm with trial site for exact values)
- You are currently pregnant or breastfeeding
- You have received high doses of a steroid called Methylprednisolone by drip (IV) in the last 4 weeks
- You have used a type of medication called biological therapy in the last 3 months
- You have received intravenous immunoglobulins or a blood-filtering treatment called plasmapheresis in the last 6 months
- You currently have an active infection
- You have a history of cancer
- You have another medical condition that already requires you to take steroid medication regularly
- You are unlikely to follow the trial's treatment plan or attend appointments (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Gener Ismail, MD, PhD, Institutul Clinic Fundeni
Phone: 0040721256797
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Percentage of participants with a histological remission
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.